Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Clinical trial NCT00006226 · COMPLETED

Trial details

NCT number: NCT00006226
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia

Start date: 2000-09-01
Primary completion: 2007-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.